Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat

European Journal of Pharmacology

Volumn 573, Issue 1-3, 2007, Pages 75-83

  Caram Salas, Nadia L ^a   Reyes García, Gerardo ^b   Bartoszyk, Gerd D ^c   Araiza Saldaña, Claudia I ^a   Ambriz Tututi, Mónica ^a   Rocha González, Héctor I ^a   Arreola Espino, Rosaura ^d   Cruz, Silvia L ^a   Granados Soto, Vinicio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

^c MERCK KGAA   (Germany)

^d UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

Author keywords

Asimadoline; ICI 204448; Neuropathic pain; Periaqueductal grey; Spinal cord; opioid receptor agonists

Indexed keywords

3 [1 (3,4 DICHLORO N METHYLPHENYLACETAMIDO) 2 (1 PYRROLIDINYL)ETHYL]PHENOXYACETIC ACID; ASIMADOLINE; ICI 20448; KAPPA OPIATE RECEPTOR; MESSENGER RNA; NALOXONE; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; FEMALE; NERVE LIGATION; NEUROPATHIC PAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SPINAL GANGLION; SPINAL NERVE;

EID: 34848866915     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.06.034     Document Type: Article

References (48)

1. Barber A., Bartoszyk G.D., Bender H.M., Gottschlich R., Greiner H.E., Harting J., Mauler F., Minck K.O., Murray R.D., Simon M., and Seyfried C.A. A pharmacological profile of the novel, peripherally-selective kappa-opioid receptor agonist, EMD 61753. Br. J. Pharmacol. 113 (1994) 1317-1327
2. Barber A., and Gottschlich R. Novel developments with selective, non-peptidic kappa-opioid receptor agonists. Expert Opin. Investig. Drugs 6 (1997) 1351-1368
3. Barrett A.C. Low efficacy opioids: implications for sex differences in opioid antinociception. Exp. Clin. Psychopharmacol. 14 (2006) 1-11
4. Barrett A.C., Smith E.S., and Picker M.J. Sex-related differences in mechanical nociception and antinociception produced by mu-and kappa-opioid receptor agonists in rats. Eur. J. Pharmacol. 452 (2002) 163-173
5. Bileviciute-Ljungar I., and Spetea M. Contralateral, ipsilateral and bilateral treatments with the kappa-opioid receptor agonist U-50,488H in mononeuropathic rats. Eur. J. Pharmacol. 494 (2004) 139-146
6. Binder W., and Walker J.S. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis. Br. J. Pharmacol. 124 (1998) 647-654
7. Binder W., Carmody J., and Walter J. Effect of gender on anti-inflammatory and analgesic actions of two kappa-opioids. J. Pharmacol. Exp. Ther. 292 (2000) 303-309
8. Catheline G., Guilbaud G., and Kayser V. Peripheral component in the enhanced antinociceptive effect of systemic U-69,593, a kappa-opioid receptor agonist in mononeuropathic rats. Eur. J. Pharmacol. 357 (1998) 171-178
9. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53 (1994) 55-63
10. Chen S.R., and Pan H.L. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology 99 (2003) 1409-1414
11. Craft R.M., and Bernal S.A. Sex differences in opioid antinociception: kappa and 'mixed action' agonists. Drug Alcohol Depend. 63 (2001) 215-228
12. Delvaux M., Beck A., Jacob J., Bouzamondo H., Weber F.T., and Frexinos J. Effect of asimadoline, a kappa opioid agonist, on pain induced by colonic distension in patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 20 (2004) 237-246
13. Eliav E., Herzberg U., and Caudle R.M. The kappa opioid agonist GR89,696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathy. Pain 79 (1999) 255-264
14. Fields H.L. State-dependent opioid control of pain. Nat. Rev. 5 (2004) 565-575
15. Fields H.L., Heinricher M.M., and Manson P. Neurotransmitters in nociceptive modulatory circuits. Ann. Rev. Neurosci. 14 (1991) 219-245
16. Field M.J., Carnell A.J., Gonzalez M.I., McCleary S., Oles R.J., Smith R., Hughes J., and Singh L. Enadoline, a selective kappa-opioid receptor agonist shows potent antihyperalgesic and antiallodynic actions in a rat model of surgical pain. Pain 80 (1999) 383-389
17. Gottschlich R., Krug M., Barber A., and Devant R.M. Kappa-opioid activity of the four stereoisomers of the peripherally selective kappa-agonists, EMD 60,400 and EMD 61,753. Chirality 6 (1994) 685-689
18. Gutstein H.B., Mansour A., Watson S.J., Akil H., and Fields H.L. Mu and kappa opioid receptors in periaqueductal grey and rostral ventromedial medulla. Neuroreport 9 (1998) 1777-1781
19. Hao J.X., Yu W., Wiesenfeld-Hallin Z., and Xu X.J. Treatment of chronic allodynia in spinally injured rats: effects of intrathecal selective opioid receptor agonists. Pain 75 (1998) 209-217
20. Heinricher M.M., Cheng Z.F., and Fields H.L. Evidence for two classes of nociceptive modulating neurons in the periaqueductal grey. J. Neurosci. 7 (1987) 271-278
21. Holtman J.R., and Wala E.P. Characterization of the antinociceptive effect of oxycodone in male and female rats. Pharmacol. Biochem. Behav. 83 (2006) 100-108
22. Horwell D.C. Kappa opioid analgesics. Drugs Future 13 (1988) 1061-1070
23. Husbands S.M. Kappa-opioid receptor ligands. Expert Opinion Ther. Pat. 14 (2004) 1725-1741
24. Jolivalt C.G., Jiang Y., Freshwater J.D., Bartoszyk G.D., and Calcutt N.A. Dynorphin A, kappa opioid receptors and the antinociceptive efficacy of asimadoline in streptozotocin-induced diabetic rats. Diabetologia 49 (2006) 2775-2785
25. Joshi S.K., and Gebhart G.F. Nonopioid actions of U50,488 enantiomers contribute to their peripheral cutaneous antinociceptive effects. J. Pharmacol. Exp. Ther. 305 (2003) 919-924
26. Keïta H., Kayser V., and Guilbaud G. Antinociceptive effect of a kappa-opioid receptor agonist that minimally crosses the blood-brain barrier (ICI 204448) in a rat model of mononeuropathy. Eur. J. Pharmacol. 277 (1995) 275-280
27. Kim H.K., and Chung K. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 50 (1992) 355-363
28. Lozano-Cuenca J., Castañeda-Hernández G., and Granados-Soto V. Peripheral and spinal mechanisms of antinociceptive action of lumiracoxib. Eur. J. Pharmacol. 513 (2005) 81-91
29. Machelska H., Pfluger M., Weber W., Piranvisseh-Volk M., Daubert J.D., Dehaven R., and Stein C. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J. Pharmacol. Exp. Ther. 290 (1999) 354-361
30. Mansour A., Burke S., Pavlic R.J., Akil H., and Watson S.J. Immunohistochemical localization of the cloned kappa 1 receptor in the rat CNS and pituitary. Neuroscience 71 (1996) 671-690
31. Minami M. Molecular pharmacology of opioid receptors. Nippon Yakurigaku Zasshi. 123 (2004) 95-104
32. Minami M., Maekawa K., Yabuuchi K., and Satoh M. Double in situ hybridization study on coexistence of mu-, delta-and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia. Brain Res. Mol. Brain Res. 30 (1995) 203-210
33. Moreau J.L., and Fields H.L. Evidence for GABA involvement in midbrain control of medullary neurons that modulate nociceptive transmission. Brain Res. 397 (1986) 37-46
34. Pace M.C., Mazzariello L., Passavanti M.B., Sansone P., Barbarisi M., and Aurilio C. Neurobiology of pain. J. Cell Physiol. 209 (2006) 8-12
35. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. (1986), Academic Press, San Diego, CA
36. Pertovaara A., and Almeida A. In: Cervero F., and Jensen T.S. (Eds). Descending Inhibitory Systems. Handbook of Clinical Neurology vol. 81 (2006), Elsevier, Amsterdam 179-192
37. Pfeiffer A., Knepel W., Braun S., Meyer H.D., Lohmann H., and Brantl V. Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man. Horm. Metab. Res. 18 (1986) 842-848
38. Porreca F., Ossipov M.H., and Gebhart G.F. Chronic pain and medullary descending facilitation. Trends Neurosci. 25 (2002) 319-325
39. Rosin A., van der Ploeg I., and Georgieva J. Basal and cocaine-induced opioid receptor gene expression in the rat CNS analyzed by competitive reverse transcription PCR. Brain Res. 28 (2000) 102-109
40. Sounvoravong S., Takahashi M., Nakashima M.N., and Nakashima K. Disability of development of tolerance to morphine and U-50,488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice. J. Pharmacol. Sci. 94 (2004) 305-312
41. Stoffel E.C., Ulibarri C.M., Folk J.E., Rice K.C., and Craft R.M. Gonadal hormone modulation of mu, kappa, and delta opioid antinociception in male and female rats. J. Pain 6 (2005) 261-274
42. Sung B., Loh H.H., and Wei L. Association of kappa opioid receptor mRNA upregulation in dorsal root ganglia with mechanical allodynia in mice following nerve injury. Neurosci. Lett. 291 (2000) 163-166
43. Vaughan C.W., Bagley E.E., Drew G.M., Schuller A., Pintar J.E., Hack S.P., and Christie M.J. Cellular actions of opioids on periaqueductal grey neurons from C57B16/J mice and mutant mice lacking MOR-1.Br. J. Pharmacol. 139 (2003) 362-367
44. Walker J., Catheline G., Guilbaud G., and Kayser V. Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCI-neuropathic rats. Pain 83 (1999) 509-516
45. Xu M., Petraschka M., McLaughlin J.P., Westenbroek R.E., Caron M.G., Lefkowitz R.J., Czyzyk T.A., Pintar J.E., Terman G.W., and Chavkin C. Neuropathic pain activates the endogenous kappa opioid system in mouse spinal cord and induces opioid receptor tolerance. J. Neurosci. 24 (2004) 4576-4584
46. Yaksh T.L. Pharmacology and mechanisms of opioid analgesic activity. Acta Anaesthesiol. Scand. 41 (1997) 94-111
47. Yaksh T.L., and Rudy T.A. Chronic catheterization of the spinal subarachnoid space. Physiol. Behav. 17 (1976) 1031-1036
48. Zimmerman M. Ethical guides for investigations on experimental pain in conscious animals. Pain 16 (1983) 109-110